Loading stock data…
CYRX
$10.35+0.09 (+0.88%)
Market ClosedLast close May 1
Cryoport, Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Cryoport, Inc. in the Industrials sector is trading at $10.35. The stock is currently near its 52-week high of $11.45, remaining 13.1% above its 200-day moving average. Technical signals show neutral RSI of 61 and bearish MACD signal, explaining why CYRX maintains its current momentum and trend strength. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Neutral momentum (RSI 61) — price action in range
Long-term trend bullish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$10.35
Potential Upside
5%
Whystock Fair Value$10.87
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostora...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$526.72M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.69
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
14.99%
Volume
Today's trading volume
305,757
Recent News
Is It Too Late To Consider Buying Cryoport, Inc. (NASDAQ:CYRX)?
Cryoport, Inc. ( NASDAQ:CYRX ), is not the largest company out there, but it saw significant share price movement...
Cryoport, Inc. Q4 2025 Earnings Call Summary
Moby summary of Cryoport, Inc.'s Q4 2025 earnings call
CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue
CryoPort Inc (CYRX) surpasses revenue expectations with a 29% increase in commercial cell and gene therapy, setting a strong foundation for 2026.
CryoPort Q4 Earnings Call Highlights
CryoPort (NASDAQ:CYRX) reported fiscal 2025 results that management characterized as a year of “strong progress,” highlighted by revenue above prior guidance, continued commercial cell and gene therapy momentum, and further steps toward profitability. Fiscal 2025 results and mix For the full year,
Cryoport (CYRX) Q4 2025 Earnings Call Transcript
As a reminder, Cryoport, Inc. has uploaded their fourth quarter and full year 2025 in review document to the main page of the Cryoport, Inc. website. This document provides a review of Cryoport, Inc.'s financial and operational performance and the general business outlook. Before I turn the call over to Jerry, please note that because of the strategic partnership that has been established with DHL and the related sale of CryoPDP to DHL, CryoPDP's financials, which were previously a part of Cryoport, Inc.'s Life Sciences and Services reportable segment, are now presented as discontinued operations.